CRL Filing
144Filing Date: Aug 6, 2026
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) · Proposed Sale (Form 144) SEC Filing
Insider Proposed Sale Notice
descriptionView SEC Filing
ACC: 0001969223-26-000853open_in_new
Sale Plan
Victoria Creamer
Officer·CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
Proposed
CommonNYSE
Shares4.18K
Est. DateAug 6
Market Value$1.09M
BrokerUBS Financial Services Inc
AcquisitionStock Option Exercise · Charles River Laboratories International, Inc.
Acquired DateAug 6, 2026
Amount Acquired4.18K
% Outstanding0.0087%
Exercise / Payment Details
Paid: Aug 6, 2026Method: CASH
Signature & Compliance expand_more
Notice DateAug 6, 2026
Signature /s/JOSEPH CASSIDY, for UBS Financial Services Inc, as attorney-in-fact for Victoria Creamer
Issuer Info expand_more
CompanyCharles River Laboratories International, Inc.
CIK0001100682
SEC File No.001-15943
Phone4242153534
Address251 Ballardvale Street, Wilmington, MA 01887